Stock Analiz

Healthequity, Inc. (HQY) stock forecast and price target

Price $103.46 · data as of November 13, 2026

12-month price target

Average target$120.67
Upside / downside+16.6%
Analysts15
ConsensusNone
Low $108.00Average $120.67High $142.00

Gold marker: average target · white marker: today’s price ($103.46)

Analyst ratings

Strong buy 5Buy 10Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends January 31, 2027
$4.72+18.1%$1.4B
Next fiscal year
ends January 31, 2028
$5.52+16.8%$1.5B
Quarter after
ends January 31, 2027
$1.10+16.1%$364M

Consensus of the analysts covering Healthequity, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 16.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Healthequity’s intrinsic value about 50% below today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Healthequity stock price target?

The average 12-month target from 15 analysts is $120.67, 16.6% above the current price of $103.46 Targets range from $108.00 to $142.00.

Is Healthequity a buy according to analysts?

The consensus rating is “None” (5 strong buy, 10 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Healthequity expected to earn?

Analysts expect EPS of $4.72 for the fiscal year ending January 31, 2027 and $5.52 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.